Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $137.04 | 2 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Endo Pharmaceuticals Inc. | $111.83 | 1 | $0 (2017) |
| Bioventus LLC | $25.21 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $25.21 | 1 | Bioventus LLC ($25.21) |
| 2017 | $111.83 | 1 | Endo Pharmaceuticals Inc. ($111.83) |
All Payment Transactions
2 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/19/2022 | Bioventus LLC | Durolane (Device) | Food and Beverage | In-kind items and services | $25.21 | General |
| Category: Orthopedics/Orthopedic Surgery | ||||||
| 06/20/2017 | Endo Pharmaceuticals Inc. | XIAFLEX (Biological) | Food and Beverage | In-kind items and services | $111.83 | General |
| Category: ORTHOPEDIC | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 24 | 1,899 | 7,959 | $792,797 | $192,573 |
| 2022 | 24 | 1,853 | 6,180 | $842,916 | $202,261 |
| 2021 | 24 | 2,140 | 5,468 | $840,064 | $198,358 |
| 2020 | 21 | 1,849 | 4,039 | $617,596 | $142,261 |
All Medicare Procedures & Services
93 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J3304 | Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg | Office | 2023 | 36 | 2,752 | $98,081 | $36,028 | 36.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 302 | 496 | $64,480 | $32,097 | 49.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 225 | 288 | $54,720 | $24,861 | 45.4% |
| J7323 | Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose | Office | 2023 | 66 | 252 | $65,520 | $24,474 | 37.4% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 220 | 466 | $187,785 | $23,535 | 12.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 120 | 120 | $36,960 | $13,266 | 35.9% |
| 20611 | Aspiration and/or injection of fluid large joint using ultrasound guidance | Office | 2023 | 108 | 146 | $87,024 | $10,040 | 11.5% |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | Office | 2023 | 188 | 1,005 | $15,055 | $5,070 | 33.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 70 | 70 | $15,050 | $4,939 | 32.8% |
| 73564 | X-ray of knee, 4 or more views | Office | 2023 | 92 | 105 | $21,470 | $3,693 | 17.2% |
| 73721 | Mri scan of leg joint without contrast | Office | 2023 | 28 | 29 | $35,030 | $3,019 | 8.6% |
| 72148 | Mri scan of lower spinal canal without contrast | Office | 2023 | 20 | 20 | $40,118 | $1,796 | 4.5% |
| 73502 | X-ray of hip, 2-3 views | Office | 2023 | 45 | 45 | $10,800 | $1,434 | 13.3% |
| 20550 | Injection into tendon or ligament | Office | 2023 | 28 | 36 | $8,892 | $1,379 | 15.5% |
| 73030 | X-ray of shoulder, minimum of 2 views | Office | 2023 | 53 | 57 | $10,614 | $1,367 | 12.9% |
| 76942 | Ultrasonic guidance for needle placement | Office | 2023 | 29 | 33 | $11,550 | $1,363 | 11.8% |
| 72100 | X-ray of lower and sacral spine, 2-3 views | Office | 2023 | 41 | 41 | $7,298 | $1,166 | 16.0% |
| 73110 | X-ray of wrist, minimum of 3 views | Office | 2023 | 20 | 20 | $3,360 | $641.13 | 19.1% |
| 20605 | Aspiration and/or injection of fluid from medium joint | Office | 2023 | 12 | 14 | $3,794 | $559.69 | 14.8% |
| 72040 | X-ray of upper spine, 2-3 views | Office | 2023 | 18 | 18 | $3,150 | $474.56 | 15.1% |
| 73610 | X-ray of ankle, minimum of 3 views | Office | 2023 | 11 | 16 | $3,024 | $441.12 | 14.6% |
| 73562 | X-ray of knee, 3 views | Office | 2023 | 13 | 13 | $2,626 | $394.03 | 15.0% |
| 73630 | X-ray of foot, minimum of 3 views | Office | 2023 | 13 | 14 | $2,590 | $358.40 | 13.8% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 141 | 1,903 | $3,806 | $176.85 | 4.6% |
| J7323 | Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose | Office | 2022 | 77 | 289 | $75,140 | $29,311 | 39.0% |
About Dr. Jason Hix, MD
Dr. Jason Hix, MD is a Sports Medicine healthcare provider based in Elkhart, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/10/2006. The National Provider Identifier (NPI) number assigned to this provider is 1023029741.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jason Hix, MD has received a total of $137.04 in payments from pharmaceutical and medical device companies, with $25.21 received in 2022. These payments were reported across 2 transactions from 2 companies. The most common payment nature is "Food and Beverage" ($137.04).
As a Medicare-enrolled provider, Hix has provided services to 7,741 Medicare beneficiaries, totaling 23,646 services with total Medicare billing of $735,454. Data is available for 4 years (2020–2023), covering 93 distinct procedure/service records.
Practice Information
- Specialty Sports Medicine
- Location Elkhart, IN
- Active Since 08/10/2006
- Last Updated 12/04/2014
- Taxonomy Code 207QS0010X
- Entity Type Individual
- NPI Number 1023029741
Products in Payments
- XIAFLEX (Biological) $111.83
- Durolane (Device) $25.21
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.